advertisement
11.4 Prostaglandins (31)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins8864 Effects of prostaglandin analogues on human ciliary muscle and trabecular meshwork cells
Zhao X; Pearson KE; Stephan DA; Russell P
Investigative Ophthalmology and Visual Science 2003; 44: 1945-1952
8886 Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours
Wentzel P; Bergh K; Wallin O; Niemela P; Stjernschantz J
Pigment Cell Research 2003; 16: 43-49
9183 Effects of 0.005% Latanoprost on Ocular Anterior Structures and Ciliary Body Thickness
Marchini G; Ghilotti G; Bonadimani M; Babighian S
Journal of Glaucoma 2003; 12: 295-300
8944 Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma
Agarwal HC; Gupta V; Sihota R
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 105-112
8943 The free amino acids and the aqueous humor pH after antiglaucomatics in vitro
Veselovsky J; Olah Z; Vesela A; Gressnerova S
Bratisl Lek Listy 2003; 104: 14-18
8947 Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension
Netland PA; Mroz M; Rosner SA; Katzman B; Macy JI
Advances in Therapy 2003; 20: 20-30
8950 Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily
Stewart WC; Stewart JA; Day D; Sharpe ED
Acta Ophthalmologica Scandinavica 2003; 81: 242-246
8948 Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
Thomas R; Parikh R; Muliyil J; George R; Paul P; Abraham LM
Indian Journal of Ophthalmology 2003; 51: 123-128
8946 Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double masked, parallel clinical trials
Zabriskie N; Netland PA
Advances in Therapy 2003; 20: 92-100
8951 Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol
Goto Y; Ibaraki N; Miyake K
Archives of Ophthalmology 2003; 121: 835-839
8952 Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide
Hommer A; Kapik B; Shams N; The Unoprostone Adjunctive Therapy Study Group
British Journal of Ophthalmology 2003; 87: 592-598
8953 Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination
Konstas AG; Papapanos P; Tersis I; Houliara D; Stewart WC
Ophthalmology 2003; 110: 1357-1360
8959 Study on hypotensive effect of latanoprost vs timolol-dorzolamide association
Luque-Aranda R; Cabarga Del Nozal C; Silva-Silva G; Vazquez-Salvi A; Garcia-Campos JM
Archivos de la Sociedad Española de Oftalmologia 2002; 77: 205-210
8978 Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension
Abelson MB; Mroz M; Rosner SA; Dirks MS; Hirabayashi D
Advances in Therapy 2003; 20: 1-13
8976 Ocular hypotensive efficacy of bimatoprost when used as a replacement for latanoprost in the treatment of glaucoma and ocular hypertension
Bournias TE; Lee D; Gross R; Mattox C
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 193-203
8964 Comparison of iridial pigmentation between latanoprost and isopropyl unoprostone: a long term prospective comparative study
Chiba T; Kashiwagi K; Chiba N; Ishijima K; Furuichi M; Kogure S; Abe K; Tsukahara S
British Journal of Ophthalmology 2003; 87: 956-959
8965 Replacing maximum-tolerated medications with latanoprost versus adding latanoprost to maximum-tolerated medications: a two-center randomized prospective trial
Gandolfi SA; Rossetti L; Cimino L; Mora P; Tardini M; Orzalesi N
Journal of Glaucoma 2003; 12: 347-353
8982 The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue
Hellberg MR; Ke TL; Haggard K; Klimko PG; Dean TR; Graff G
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 97-103
8963 Increased periocular pigmentation with ocular hypotensive lipid use in African Americans
Herndon LW; Williams RD; Wand M; Asrani S
American Journal of Ophthalmology 2003; 135: 713-715
8967 Unoprostone isopropyl pretreatment decreases endothelin-1 release and the intraocular pressure spike induced by laser trabeculoplasty in the rabbit
Holló G; Visontai Z; Lakatos P; Vargha P
Ophthalmologica 2003; 217: 231-236
8971 Update on prostaglandin analogs
Hylton C; Robin AL
Current Opinions in Ophthalmology 2003; 14: 65-69
8974 Ocular hypotensive effect of combined instillation of carteolol and latanoprost
Kawai H; Hayashi R; Shoji N; Morita T; Hirayama S; Nemoto T; Kodama Y; Shimizu K
Japanese Journal of Clinical Ophthalmology 2003; 57: 709-713
8987 Aqueous humour flow after a single oral dose of isosorbide-5-mononitrate in healthy volunteers
Kotikoski H; Oksala O; Vapaatalo H; Aine E
Acta Ophthalmologica Scandinavica 2003; 81: 355-360
8986 Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression
Liang Y; Li C; Guzman VM; Evinger AJ 3rd; Protzman CE; Krauss AH; Woodward DF
Journal of Biological Chemistry 2003; 278: 27267-27277
8981 Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo(2.2.1)heptane derivatives
Mitsumori S; Tsuri T; Honma T; Hiramatsu Y; Okada T; Hashizume H; Inagaki M; Arimura A; Yasui K; Asanuma F
Journal of Medicinal Chemistry 2003; 46: 2436-2445
